Pengfei Fu1, Xinbiao Guo2, Felix Man Ho Cheung1, Ken Kin Lam Yung3. 1. Department of Biology, Hong Kong Baptist University, Hong Kong, SAR, China. 2. Department of Occupational & Environmental Health Sciences, Peking University School of Public Health, Beijing, China. 3. Department of Biology, Hong Kong Baptist University, Hong Kong, SAR, China. Electronic address: kklyung@hkbu.edu.hk.
Abstract
BACKGROUND: Recent systematic review and meta-analyses have tried to identify an association between PM2.5 exposure and stroke, but few could find a conclusive and comprehensive evidence. Moreover, the associations between PM2.5, neurodegenerative diseases and neurodevelopmental disorders have never been reviewed. We aimed to assess the effects of PM2.5 exposure on stroke, dementia, Alzheimer's disease, autism spectrum disorder (ASD), Parkinson's disease, and mild cognitive impairment (MCI). METHODS: We searched PubMed and CNKI databases for articles published until June 2018. Studies were eligible for analysis if they were human studies and provided risk estimates with 95% CI. We screened 1645 articles and identified 80 eligible studies covering 26 countries across all continents except Antarctica. Risks of incidence and mortality were extracted and stratified by types of neurological disorders, PM2.5 concentration and duration of PM2.5 exposure. RESULTS: We found significant association between PM2.5 exposure and stroke, dementia, Alzheimer's disease, ASD, Parkinson's disease. The risks of ischemic and hemorrhagic stroke were higher than that of stroke in general, and that hemorrhagic stroke had by far the highest mortality. The risk of stroke for heavily polluted countries was significantly higher than that of lightly polluted countries. Short- and long-term PM2.5 exposure was associated with increased risks of stroke (short-term odds ratio 1.01 [per 10 μg/m3 increase in PM2.5 concentrations], 95% CI 1.01-1.02; long-term 1.14, 95% CI 1.08-1.21) and mortality (short-term 1.02, 95% CI 1.01-1.04; long-term 1.15, 95% CI 1.07-1.24) of stroke. Long-term PM2.5 exposure was associated with increased risks of dementia (1.16, 95% CI 1.07-1.26), Alzheimer's disease (3.26, 95% 0.84-12.74), ASD (1.68, 95% CI 1.20-2.34), and Parkinson's disease (1.34, 95% CI 1.04-1.73). CONCLUSIONS: There is a strong association between PM2.5 exposure and neurological disorders. National governments should exert greater efforts to improve air quality given its health implications.
BACKGROUND: Recent systematic review and meta-analyses have tried to identify an association between PM2.5 exposure and stroke, but few could find a conclusive and comprehensive evidence. Moreover, the associations between PM2.5, neurodegenerative diseases and neurodevelopmental disorders have never been reviewed. We aimed to assess the effects of PM2.5 exposure on stroke, dementia, Alzheimer's disease, autism spectrum disorder (ASD), Parkinson's disease, and mild cognitive impairment (MCI). METHODS: We searched PubMed and CNKI databases for articles published until June 2018. Studies were eligible for analysis if they were human studies and provided risk estimates with 95% CI. We screened 1645 articles and identified 80 eligible studies covering 26 countries across all continents except Antarctica. Risks of incidence and mortality were extracted and stratified by types of neurological disorders, PM2.5 concentration and duration of PM2.5 exposure. RESULTS: We found significant association between PM2.5 exposure and stroke, dementia, Alzheimer's disease, ASD, Parkinson's disease. The risks of ischemic and hemorrhagic stroke were higher than that of stroke in general, and that hemorrhagic stroke had by far the highest mortality. The risk of stroke for heavily polluted countries was significantly higher than that of lightly polluted countries. Short- and long-term PM2.5 exposure was associated with increased risks of stroke (short-term odds ratio 1.01 [per 10 μg/m3 increase in PM2.5 concentrations], 95% CI 1.01-1.02; long-term 1.14, 95% CI 1.08-1.21) and mortality (short-term 1.02, 95% CI 1.01-1.04; long-term 1.15, 95% CI 1.07-1.24) of stroke. Long-term PM2.5 exposure was associated with increased risks of dementia (1.16, 95% CI 1.07-1.26), Alzheimer's disease (3.26, 95% 0.84-12.74), ASD (1.68, 95% CI 1.20-2.34), and Parkinson's disease (1.34, 95% CI 1.04-1.73). CONCLUSIONS: There is a strong association between PM2.5 exposure and neurological disorders. National governments should exert greater efforts to improve air quality given its health implications.
Authors: Lianfa Li; Mariam Girguis; Frederick Lurmann; Nathan Pavlovic; Crystal McClure; Meredith Franklin; Jun Wu; Luke D Oman; Carrie Breton; Frank Gilliland; Rima Habre Journal: Environ Int Date: 2020-09-24 Impact factor: 9.621
Authors: Diana Younan; Xinhui Wang; Ramon Casanova; Ryan Barnard; Sarah A Gaussoin; Santiago Saldana; Andrew J Petkus; Daniel P Beavers; Susan M Resnick; JoAnn E Manson; Marc L Serre; William Vizuete; Victor W Henderson; Bonnie C Sachs; Joel A Salinas; Margaret Gatz; Mark A Espeland; Helena C Chui; Sally A Shumaker; Stephen R Rapp; Jiu-Chiuan Chen Journal: Neurology Date: 2020-11-18 Impact factor: 9.910
Authors: Rukhsana Rashid; Felisha Chong; Shahid Islam; Maria Bryant; Rosemary R C McEachan Journal: BMC Public Health Date: 2021-07-03 Impact factor: 3.295
Authors: Edwin van Wijngaarden; David Q Rich; Wangjian Zhang; Sally W Thurston; Shao Lin; Daniel P Croft; Stefania Squizzato; Mauro Masiol; Philip K Hopke Journal: Ann Epidemiol Date: 2020-09-30 Impact factor: 3.797